Effectiveness of Opicapone in Parkinson's according to baseline use of MAO-B inhibitors & DA: real-world OPTIPARK study

被引:0
作者
Reichmann, H. [1 ]
Warnecke, T. [2 ]
Lees, A. [3 ]
Martins, D. [4 ]
Magalhaes, D. [4 ]
Rocha, J. [4 ]
Soares-da-Silva, P. [4 ]
机构
[1] Univ Dresden, Dept Neurol, Dresden, Germany
[2] Univ Munster, Dept Neurol, Munster, Germany
[3] Natl Hosp Neurol & Neurosurg, Dept Clin & Movement Neurosci, London, England
[4] BIAL Portela & Ca SA, Coronado, Portugal
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-218
引用
收藏
页码:352 / 353
页数:2
相关论文
共 3 条
  • [1] [Anonymous], 2017, JAMA NEUROL, P197
  • [2] Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
    Ferreira, Joaquim J.
    Lees, Andrew
    Rocha, Jose-Francisco
    Poewe, Werner
    Rascol, Olivier
    Soares-da-Silva, Patricio
    [J]. LANCET NEUROLOGY, 2016, 15 (02) : 154 - 165
  • [3] Reichmann H, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00187-1